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PCL-SS-N 3
Acrylate-PCL-SS-N 3 2-((2-bromoethyl)disulfanyl)ethanol (4). 2 Triphenylphosphine (1.3 g, 5.0 mmol) was added to an ice-cold solution of 2-hydroxyethyl disulfide (0.77 g, 5.0 mmol) in dichloromethane (300 mL). After the mixture was stirred at 0°C for 15 min, carbon tetrabromide (1.66 g, 5.0 mmol) was added slowly. The mixture was stirred for a further 10 h and then washed with water (2 × 150 mL) and brine (150 mL).
The organic layer was dried (Na 2 SO 4 ), concentrated, and purified by silica gel column chromatography (20% ethyl acetate in petroleum ether) to afford compound 4 (0.675 g, 62%) as a colorless oil. 1 
2-((2-azidoethyl)disulfanyl)ethanol (5)
. 1 Sodium azide (0.65 g, 10 mmol) was added to a solution of compound 4 (1.08 g, 5 mmol) in dry N,N-dimethylformamide (40 mL), and the mixture was stirred at S5 80°C for 10 h. The product was extracted three times with ethyl ether. The combined organic layer was washed with brine and dried over anhydrous Na 2 SO 4 . Following filtration and evaporation, the product was dried under a vacuum to give compound 5 (0.643 g, 78%) as a yellow oil. 1 Acrylate-PCL-SS-N 3 . 4 The terminal esterification of PCL-SS-N 3 to synthesize acrylate-PCL-SS-N 3 was performed as follows: PCL-SS-N 3 6 (930 mg, 0.1 mmol) and TEA (101 mg, 1 mmol) were dissolved in 5 mL 1,2-dichloroethane. After the mixture was stirred at 0°C for 15 min, acryloyl chloride (80%, 113 mg, 1 mmol) in 5 mL 1,2-dichloroethane was added dropwise. Subsequently, the reaction mixture was stirred at 25°C for a further 3 h and then refluxed for 1 day. The resulting Acrylate-PCL-SS-N 3 was dissolved in dichloromethane and precipitated four times in methanol. The purified acrylate-S6 PCL-SS-N 3 was dried under a vacuum at 25°C (701 mg, yield: 75%). 1 was used as the catalyst. The feed ratio of CL to 2-azidoethanol was 100/1 (M CL /M 6 ). Briefly, CL (11.4 g, 100 mmol), 2-azidoethanol (87 mg, 1 mmol), and Sn(Oct) 2 (0.003 mg) were added to a 50-mL reactor. The reactor was degassed with three freeze-evacuate-thaw cycles. The reaction was stirred to reflux under N 2 for 12 h. The resulting PCL-N 3 was dissolved in dichloromethane and precipitated four S7 times in methanol. The purified PCL-N 3 was dried under a vacuum at 25°C (9.7 g, yield: 85.0%). 1 H NMR (400 MHz, CDCl 3 , δ): 4.25 (t, J = 5.0 Hz, 2H, N 3 CH 2 CH 2 OCO-), 4.05 (t, J = 6.7 Hz, 169H, - 3 .64 (t, J = 6.5 Hz, 2H, HOCH 2 CH 2 CH 2 CH 2 CH 2 OCO-), 3.47 (t, J = 5.1
Acrylate-PCL-N 3 . 4 The terminal esterification of PCL-N 3 to synthesize acrylate-PCL-N 3 was performed as follows: PCL-N 3 (890 mg, 0.1 mmol) and TEA (101 mg, 1 mmol) were dissolved in 5 mL 1,2-dichloroethane at 0°C. Acryloyl chloride (80%, 113 mg, 1 mmol) in 10 mL 1,2-dichloroethane was added dropwise. Subsequently, the reaction mixture was stirred at 25°C for 3 h and then refluxed for 1 day. The resulting acrylate-PCL-N 3 was dissolved in dichloromethane and precipitated four times in methanol. The purified acrylate-PCL-SS-N 3 was dried under a vacuum at 25°C (676 mg, yield: 71.7%). 1 H NMR (400 MHz, CDCl 3 , δ): 6.37-6.42 (m, 1H, -CH 2 CH 2 OCOCH=CHH), 6.08-6.15 (m, 1H, - 6 Potassium carbonate (13 mmol, 1.79 g) in water (30 mL) was added to an ice-cold solution of 2-bromoethanol (10 mmol, 1.24 g) in dichloromethane (300 mL). After the S8 mixture was stirred at 0°C for 15 min, bromoacetyl bromide (13 mmol, 2.61 g) in dichloromethane (30 mL) was added drop-wise. The mixture was stirred for 3 h, and the organic phase was separated, dried over Na 2 SO 4 , filtered, and evaporated to give the product at 81% yield. 1 The organic phase were washed with brine and dried over anhydrous Na 2 SO 4 . Following filtration and evaporation, the product was dried under a vacuum to give dansyl-n-butyl sulfonamide as light-green solid (1.25 g, 82%). 1 Preparation of the SCMs. 1 SCMs were synthesized in our laboratory according to our previously reported procedures. Briefly, CuCl 2 (10 μL 6.7 mg/mL aqueous solution, 0.5 μmol) and crosslinker 3 (4.3 mg, 0.025 mmol) were added to a solution of 2 (9.7 mg, 0.02 mmol) in deionized water (2.0 mL).
Sodium ascorbate (10 μL 99 mg/mL aqueous solution, 5 μmol) was added drop-wise to the above solution. The solution was stirred slowly at 25°C for 36 h and further purified by dialysis against deionized water (Spectra/Pore, MWCO 1000).
Typical preparation of the DMFs and nDMFs. 9 The SCMs were prepared as described above.
After cross-linking, acrylate-PCL-SS-N 3 or acrylate-PCL-N 3 (3.7 mg) in THF (4 mL), and CuCl 2 (10 μL 6.7 mg/mL aqueous solution, 0.5 μmol) were added to the solution of SCMs (10 mM, 2.0 mL).
Sodium ascorbate (10 μL 99 mg/mL aqueous solution, 5 μmol) was added drop-wise to the above solution. Following another 12-h incubation at 25°C, the PCL-functionalized SCMs were further purified by dialysis against deionized water (MWCO: 350 kDa) to obtain a translucent solution with good Tyndall phenomenon. The cross-linked procedure of DFMs is described as follows.
Divinylbenzene (DVB, 5.6 μL, 0.01 mmol in DMSO) was added to the above solution. The mixture was subjected to ultrasonication for 10 min and purified by dialysis against deionized water (MWCO: 1000 Da) to remove excess DVB. Then the 2,2-dimethoxy-2-phenylacetophenone (DMPA,10 μL 13.0 mg/mL solution in DMSO, 0.0005 mmol) were added to the solution. The reaction mixture was purged with N 2 for 30 min, transferred to a glass vial, and irradiated in a Rayonet reactor for 6 h to obtain a solution of DMFs or nDMFs. Routine 1 H NMR was used to monitor the progress of reaction. Since the value of S10 reactivity ratios in copolymerization of DVB and racrylate group is both less than 1 (r DVB < 1, r racrylate group < 1 ), the chain radicals prefer to react with another monomer. 10, 11 At the end of the copolymerization between DVB and acrylate group, the chain architecture of copolymers alternately arrange DVB and acrylate groups ( Figure S3 ). Therefore, almost all DVB molecules involving in photoreaction tended to participate in the cross-linking process to obtain the core cross-linked DFMs.
Moreover, for calculation of DVB entrapment efficiency (EE), the DVB in DFMs was extracted with ethyl acetate for three times. The content of the hydrophobic DVB measured by UV spectroscopy ( Figure S4 Typical preparation of the SCMs@D, SCMs@NR, and SCMs@HCFU. 7, 12 The materials were synthesized following our previous method. Briefly, naphthalene (D), Nile Red (NR), or HCFU in acetone (3 mg/mL, 100 μL) was added to a glass vial. Acetone was evaporated overnight, and a micellar solution of 2 (10 mM, 2.0 mL) was added. The combined solution was sonicated for 4 h in the dark until the D, NR, or HCFU dissolved. Crosslinker 3 (4.3 mg, 0.025 mmol), CuCl 2 (10 μL 6.7 mg/mL aqueous solution, 0.5 μmol), and sodium ascorbate (10 μL 99 mg/mL aqueous solution, 5 μmol) were added to the above mixture, which was stirred slowly at room temperature for 24 h and further purified by dialysis against deionized water (Spectra/Pore, MWCO 1000) to obtain SCMs@D (8.5 ± 1.6 nm), SCMs@NR (8.9 ± 1.9 nm), or SCMs@HCFU (12.5 ± 2.3 nm). The excess cargo was removed using a 0.45 μm filter. The loading content of SCMs@D and SCMs@NR were evaluated by fluorescence spectra ( Figure S11 and Figure S18 ). The loading content (LC) for SCMs@D and SCMs@NR are in the range of 1.54-4.22% and 2.12-5.61%, respectively. The loading content of SCMs@HCFU was S11 analyzed using a high-performance liquid chromatography (HPLC) system (Waters Isocratic HPLC Pump, US). The loading content (LC) for SCMs@HCFU is in the range of 2.54-5.43%.
Typical preparation of the DMFs@NR, nDMFs@NR, DMFs@HCFU, nDMFs@HCFU,
DMFs@D, DMFs@A and DMFs@D&A. 7, 12 DMFs@D, DMFs@NR, nDMFs@NR, DMFs@HCFU, and nDMFs@HCFU used in our work were synthesized similar to empty DFMs and nDMFs. DMFs@A and DMFs@D&A were synthesized using a micelle extraction technique ( Figure S9 ). Prior to loading, the given solution of dansyl-n-butyl sulfonamide (A, 3 mg/mL, 100 μL) was added in a vial. Acetone was evaporated overnight, and a micellar solution of DMFs (2.0 mL) or DMFs@D (2.0 mL) was added and ultrasonicated for 3 h to achieve maximum loading, respectively. The excess A was filtered using a 0.45μm filter. The A loading content (LC) for DMFs@A and DMFs@D&A are in the range of 3.21-4.18% and 3.19-4.09%, respectively ( Figure S12 ). 12 The critical micelle concentration (CMC) of the obtained acrylate-PCL-SS-SCMs and acrylate-PCL-SCMs was studied by fluorescence spectroscopy using pyrene as a probe. The material concentration was varied from 1.0×10 -2 to 200 μg/mL. The pyrene concentration was finally fixed at 5.4×10 -6 M. The mixed solution was sonicated for 2 h. Fluorescence excitation spectra were obtained using a Hitachi F-7000 fluorescence spectrometer at a wavelength range of 285 to 355 nm, with bandwidths of 5.0 nm for excitation and 5.0 nm for emission.
Characterization of acrylate-PCL-SS-SCMs and acrylate-PCL-SCMs.
DFMs@HCFU and nDFMs@HCFU release assay. 13 Evaluation of the release of the DFMs@HCFU and nDFMs@HCFU was carried out using the dialysis method ( Figure S21 ). In brief, 10 mL DFMs@HCFU or nDFMs@HCFU solution (3 mg/mL) was added to a dialysis bag (MWCO: S12 system was maintained at 37°C in a thermostatic incubator with a shaking speed of 120 rpm. 1.0 mL solution was collected from the corresponding different reservoirs, and 1.0 mL buffer solution (pH = 7.4) was simultaneously added to the reservoir at predetermined periods. Candida antarctica lipase B (5 U/mL) was added to the aqueous sample solutions. Following a further 24 h at 37 o C in a thermostatic incubator, HCFU was extracted three times with ethyl acetate. The samples were detected by a highperformance liquid chromatography (HPLC) system (Waters Isocratic HPLC Pump, US). The release data were averaged from triplicate.
Cell viability assay. 13 To evaluate the cytocompatibility of drug-free DFMs and nDFMs, A549 cells were seeded in 96-well culture plates and incubated at 37 °C under 5% CO 2 . The culture media were removed and replaced with of fresh media (200 µL) containing various concentrations of micelle solutions. After 48 h, the culture media were removed and fresh media (100 µL) containing 10 µL Cell Counting Kit-8 (CCK-8) solution was added to each well. The culture plates were incubated at 37 °C for another 2 h. The absorbance of each sample at 450 nm was recorded using a Varioscan Flash microplate instrument.
Penetrating ability of the DFMs@NR, DFMs@NR, and SCMs@NR into multicellular tumor spheroids (MTSs). 14 Human lung adenocarcinoma A549 cell-based multicellular tumor spheroids were cultivated using the liquid overlay method. Briefly, 6-well plates were coated with 1 mL sterile 1% agar, followed by seeding of a single-cell suspension. Cells were cultured at 37°C with 5% CO 2 until the MTSs reached approximately 300 μm in diameter. According to our previously research, flow cytometry data showed the cell influx amount of the nanoparticles with similar surface properties in 3 h was less than 5% of that in 12 h. 15, 16 So the MTSs were firstly co-incubated with DFMs@NR, nDFMs@NR, or SCMs@NR (20 μg/mL, NR) for 3 h, confirming that overwhelming majority of the S13 nanopaticles would permeate into the extracellular matrix of the MTSs. Followed by a 24-h incubation in the presence of 20 μM GSH, the spheroids were subjected to LSFM scanning after washing with PBS buffer. For quantitative cellular uptake analysis, the single-cell suspension was obtained from the MTSs using Accutase™ reagent (Invitrogen, USA), and washed with PBS (pH = 7.4) and subjected to flow cytometry analysis in triplicate.
In vitro antitumor effect on MTSs. 17 Three-day-old A549 cell-based multicellular tumor spheroids were incubated with 2 mL fresh medium containing DMFs@HCFU or nDMFs@HCFU (11.36 μg/mL, HCFU) for 3 h, followed by a 48-h incubation in the presence of 20 μM GSH. For the LIVE/DEAD® assay, the MTS culture medium was replaced with 1 mL PBS solution containing 4 μM ethidium homodimer-1 (dead cells) and 2 μM calcein AM (live cells). Following a 20-min incubation at 37°C, single spheroids were transferred to a glass dish, washed twice with PBS, and analyzed using confocal laser scanning microscopy (CLSM, Leica TCP SP5). Bright-field microscopy was used to monitor the morphological changes in MTSs induced by the treatments. In addition, A549 MTSs seeded on 6-well plates were treated in the same manner and assessed for cell viability. Briefly, MTSs were gently transferred to a new 96-well plate, to which fresh media (100 µL) containing 10 μL CCK-8 solution was added. Following a 4-h incubation, the medium containing the CCK8 reagent was transferred to empty wells prior to measuring the absorbance at 450 nm.
To evaluate the antitumor efficacy of DMFs@HCFU or nDMFs@HCFU, A549 MTSs were treated with DMFs@HCFU or nDMFs@HCFU (11.36 μg/mL, HCFU) for (2). From equations (1) and (2), the value of x/z is about 42/1. Since an SCM contained approximately 40-50 small molecule 2 surfactants according to our previous study, 1 the SCM on average grafted one acrylate-PCL-SS-N 3 group. b The nanoparticles are materials released from the DFMs upon a specific stimulus. 
